Both involve substances that produce CNS stimulation, but they differ enormously in potency and diagnostic structure: Stimulant Use Disorder applies to amphetamine-type substances and cocaine and includes a full use-disorder behavioral criteria set, while Caffeine-Related Disorders in DSM-5-TR are limited to Caffeine Intoxication and Caffeine Withdrawal -- there is no Caffeine Use Disorder category.
Stimulant use disorder can develop from recreational or prescribed-stimulant misuse at any point after initial use; caffeine intoxication or withdrawal can occur in virtually anyone who consumes caffeine regularly, reflecting caffeine's near-universal, largely normalized use pattern.
Stimulant use disorder follows a chronic, relapsing course typical of substance use disorders; caffeine withdrawal is typically brief, resolving within days, and caffeine intoxication resolves within hours as the substance is metabolized.
Stimulant Use Disorder is associated with marked functional impairment, weight loss, and possible stimulant-induced psychosis with heavy use; Caffeine Intoxication involves restlessness, insomnia, and GI upset, while Caffeine Withdrawal is marked chiefly by headache and fatigue.
Stimulant Use Disorder requires clinically significant impairment across the behavioral criteria set for diagnosis; caffeine-related diagnoses require clinically significant distress or impairment specifically from intoxication or withdrawal symptoms, not from a broader pattern of loss-of-control use, since no Caffeine Use Disorder exists.
A key structural exclusion is that no amount of problematic caffeine consumption alone, however habitual, can be diagnosed as a use disorder under DSM-5-TR's current substance categories, unlike stimulants, which have a fully defined use-disorder category.
The differential-defining structural point is that stimulants (amphetamine-type substances, cocaine) have a full use-disorder diagnostic category reflecting their higher abuse liability and impairment potential, while caffeine's much lower abuse liability is reflected in DSM-5-TR limiting its diagnoses to intoxication and withdrawal only.
Because both are described as 'stimulants' colloquially, learners sometimes assume caffeine has a parallel use-disorder diagnosis; DSM-5-TR deliberately does not include one, reflecting caffeine's different risk profile from amphetamine-type stimulants and cocaine.
A patient with escalating cocaine use causing job loss and failed cutdown attempts fits Stimulant Use Disorder's behavioral criteria; a patient who skips their usual three cups of coffee and develops a pounding headache and fatigue fits Caffeine Withdrawal, a much more limited and self-resolving diagnosis.
| Feature | Stimulant Use Disorder | Caffeine-Related Disorders |
|---|---|---|
| Use disorder category exists | Stimulant: yes, full behavioral criteria set | Caffeine: no Use Disorder category |
| Available diagnoses | Use Disorder, Intoxication, Withdrawal, Other Induced Disorders | Intoxication and Withdrawal only |
| Typical course of symptoms | Chronic, relapsing | Brief, self-resolving within days |
A problematic pattern of amphetamine-type substance, cocaine, or other stimulant use leading to clinically significant impairment or distress, evidenced by at least 2 of 11 criteria spanning impaired control, social impairment, risky use, and pharmacological indicators, within a 12-month period.
Clinically significant symptoms following recent caffeine consumption (Caffeine Intoxication) or following abrupt reduction/cessation of regular caffeine use (Caffeine Withdrawal) -- notably, DSM-5-TR does not include a formal Caffeine Use Disorder in its main diagnostic section.